Cargando…
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853430/ https://www.ncbi.nlm.nih.gov/pubmed/35165421 http://dx.doi.org/10.1038/s41422-022-00626-w |
_version_ | 1784653226238279680 |
---|---|
author | Zhang, Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Ji, Kai Xiong, Xiao-Chuan Qin, Qian-Shan Gao, Peng Lu, Xi-Shan Zhou, Hang-Yu Song, Hai-Feng Ying, Bo Qin, Cheng-Feng |
author_facet | Zhang, Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Ji, Kai Xiong, Xiao-Chuan Qin, Qian-Shan Gao, Peng Lu, Xi-Shan Zhou, Hang-Yu Song, Hai-Feng Ying, Bo Qin, Cheng-Feng |
author_sort | Zhang, Na-Na |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8853430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-88534302022-02-18 Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant Zhang, Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Ji, Kai Xiong, Xiao-Chuan Qin, Qian-Shan Gao, Peng Lu, Xi-Shan Zhou, Hang-Yu Song, Hai-Feng Ying, Bo Qin, Cheng-Feng Cell Res Letter to the Editor Springer Singapore 2022-02-14 2022-04 /pmc/articles/PMC8853430/ /pubmed/35165421 http://dx.doi.org/10.1038/s41422-022-00626-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Zhang, Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Ji, Kai Xiong, Xiao-Chuan Qin, Qian-Shan Gao, Peng Lu, Xi-Shan Zhou, Hang-Yu Song, Hai-Feng Ying, Bo Qin, Cheng-Feng Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
title | Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
title_full | Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
title_fullStr | Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
title_full_unstemmed | Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
title_short | Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
title_sort | rapid development of an updated mrna vaccine against the sars-cov-2 omicron variant |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853430/ https://www.ncbi.nlm.nih.gov/pubmed/35165421 http://dx.doi.org/10.1038/s41422-022-00626-w |
work_keys_str_mv | AT zhangnana rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT zhangrongrong rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT zhangyifei rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT jikai rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT xiongxiaochuan rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT qinqianshan rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT gaopeng rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT luxishan rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT zhouhangyu rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT songhaifeng rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT yingbo rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant AT qinchengfeng rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant |